Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-09-13 Purchase |
2023-09-15 6:52 pm |
HCW Biologics Inc. | HCWB | Byam Rebecca Chief Financial Officer |
5,000 | $2.098 | $10,490 | 573,946 (Direct) |
View |
| 2023-09-11 Purchase |
2023-09-13 5:33 pm |
HCW Biologics Inc. | HCWB | Byam Rebecca Chief Financial Officer |
10,000 | $2.0715 | $20,715 | 568,946 (Direct) |
View |
| 2023-09-07 Purchase |
2023-09-08 5:25 pm |
HCW Biologics Inc. | HCWB | Byam Rebecca Chief Financial Officer |
10,000 | $1.9853 | $19,853 | 558,946 (Direct) |
View |
| 2023-09-06 Purchase |
2023-09-07 4:47 pm |
HCW Biologics Inc. | HCWB | Byam Rebecca Chief Financial Officer |
5,000 | $1.9498 | $9,749 | 548,946 (Direct) |
View |
| 2023-06-09 Purchase |
2023-06-09 6:49 pm |
HCW Biologics Inc. | HCWB | Byam Rebecca Chief Financial Officer |
20,000 | $2.0643 | $41,286 | 543,946 (Direct) |
View |
| 2023-06-07 Purchase |
2023-06-08 7:24 pm |
HCW Biologics Inc. | HCWB | Byam Rebecca Chief Financial Officer |
24,696 | $2.0659 | $51,020 | 523,946 (Direct) |
View |
| 2023-06-05 Purchase |
2023-06-07 4:46 pm |
HCW Biologics Inc. | HCWB | Byam Rebecca Chief Financial Officer |
39,062 | $1.744 | $68,123 | 499,250 (Direct) |
View |
| 2023-05-25 Purchase |
2023-05-31 5:33 pm |
HCW Biologics Inc. | HCWB | Byam Rebecca Chief Financial Officer |
40,000 | $1.6386 | $65,544 | 460,188 (Direct) |
View |
| 2023-05-22 Purchase |
2023-05-24 5:25 pm |
HCW Biologics Inc. | HCWB | Byam Rebecca Chief Financial Officer |
58,486 | $1.5573 | $91,082 | 420,188 (Direct) |
View |
| 2022-09-14 Purchase |
2022-09-15 4:27 pm |
HCW Biologics Inc. | HCWB | Byam Rebecca Chief Financial Officer |
15,000 | $2.5767 | $38,651 | 327,952 (Direct) |
View |
| 2022-09-12 Purchase |
2022-09-14 3:22 pm |
HCW Biologics Inc. | HCWB | Byam Rebecca Chief Financial Officer |
30,000 | $2.6138 | $78,414 | 312,952 (Direct) |
View |
| 2022-08-30 Purchase |
2022-09-01 4:01 pm |
HCW Biologics Inc. | HCWB | Byam Rebecca Chief Financial Officer |
17,200 | $2.5531 | $43,913 | 282,952 (Direct) |
View |
| 2022-08-26 Purchase |
2022-08-30 5:20 pm |
HCW Biologics Inc. | HCWB | Byam Rebecca Chief Financial Officer |
20,000 | $2.551 | $51,020 | 265,752 (Direct) |
View |
| 2022-08-24 Purchase |
2022-08-26 4:48 pm |
HCW Biologics Inc. | HCWB | Byam Rebecca Chief Financial Officer |
90,300 | $2.5443 | $229,747 | 245,752 (Direct) |
View |
| 2022-06-13 Purchase |
2022-06-15 7:13 pm |
HCW Biologics Inc. | HCWB | Byam Rebecca Chief Financial Officer |
66,452 | $2.4198 | $160,798 | 155,452 (Direct) |
View |
| 2021-08-19 Purchase(A) |
2021-09-10 5:53 pm |
HCW Biologics Inc. | HCWB | Byam Rebecca Chief Financial Officer |
10,000 | $4.3979 | $43,979 | 62,000 (Direct) |
View |
| 2021-08-19 Purchase |
2021-08-23 7:50 pm |
HCW Biologics Inc. | HCWB | Byam Rebecca Chief Financial Officer |
10,000 | $4.3979 | $43,979 | 62,000 (Direct) |
View |
| 2021-07-22 Purchase |
2021-07-23 7:28 pm |
HCW Biologics Inc. | HCWB | Byam Rebecca Chief Financial Officer |
25,000 | $8 | $200,000 | 52,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-02-20 Option Award |
2024-02-22 2:19 pm |
N/A N/A |
HCW Biologics Inc. | HCWB | Byam Rebecca Chief Financial Officer |
760,714 | $1.4 | 1,381,909 (Direct) |
View |
| 2023-10-19 Exercise |
2023-10-23 4:44 pm |
N/A 2029-12-19 |
HCW Biologics Inc. | HCWB | Byam Rebecca Chief Financial Officer |
47,249 | $0 | 621,195 (Direct) |
View |
| 2023-10-19 Exercise |
2023-10-23 4:44 pm |
N/A N/A |
HCW Biologics Inc. | HCWB | Byam Rebecca Chief Financial Officer |
47,249 | $0.14 | 621,195 (Direct) |
View |
| 2022-11-02 Exercise |
2022-11-03 5:09 pm |
N/A 2029-12-19 |
HCW Biologics Inc. | HCWB | Byam Rebecca Chief Financial Officer |
33,750 | $0 | 408,951 (Direct) |
View |
| 2022-11-02 Exercise |
2022-11-03 5:09 pm |
N/A N/A |
HCW Biologics Inc. | HCWB | Byam Rebecca Chief Financial Officer |
33,750 | $0.14 | 408,951 (Direct) |
View |
| 2021-11-23 Exercise |
2021-11-26 12:17 pm |
N/A 2029-12-19 |
HCW Biologics Inc. | HCWB | Byam Rebecca Chief Financial Officer |
27,000 | $0 | 169,999 (Direct) |
View |
| 2021-11-23 Exercise |
2021-11-26 12:17 pm |
N/A N/A |
HCW Biologics Inc. | HCWB | Byam Rebecca Chief Financial Officer |
27,000 | $0.14 | 169,999 (Direct) |
View |
| 2021-08-29 Option Award |
2021-09-10 5:52 pm |
N/A 2031-08-28 |
HCW Biologics Inc. | HCWB | Byam Rebecca Chief Financial Officer |
215,000 | $0 | 215,000 (Direct) |
View |
Ownership |
2021-07-19 4:54 pm |
N/A N/A |
HCW Biologics Inc. | HCWB | Byam Rebecca Chief Financial Officer |
0 | $0 | 134,999 (Direct) |
View |